Search - tctmd.com

Displaying 181 - 200 of 539

Sort: Relevancy | Date

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Yael L. Maxwell

December 06, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Michael O'Riordan

October 31, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

Michael O'Riordan

October 09, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Advertisement

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Repeat Target-Lesion PCI: An Option for Public Reporting?

Elderly Women Worse Off Than Men Before and After Acute MI

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Recurrent Events Common Among Young Patients With CAD

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content